Global Crohn’s Disease Drug Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.

Published Oct 20, 2025

Length 196 Pages

SKU # APRC20561049

Description

Summary

According to APO Research, The global Crohn’s Disease Drug market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Crohn’s Disease Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Crohn’s Disease Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Crohn’s Disease Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Crohn’s Disease Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Crohn’s Disease Drug include Janssen Biotech, Takeda Pharmaceuticals, Amgen, AbbVie and Tillotts Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Crohn’s Disease Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Crohn’s Disease Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Crohn’s Disease Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Crohn’s Disease Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Crohn’s Disease Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Crohn’s Disease Drug sales, projected growth trends, production technology, application and end-user industry.

Crohn’s Disease Drug Segment by Company

Janssen Biotech
Takeda Pharmaceuticals
Amgen
AbbVie
Tillotts Pharma
Crohn’s Disease Drug Segment by Type

Aminosalicylates (5-ASA)
Antibiotics
Immunomodulators
Corticosteroids
Crohn’s Disease Drug Segment by Application

Pediatric Crohn'S Disease
Maintaining Remission (Prevention Of Flare-Ups)
Achieving Remission (The Absence Of Symptoms)
Crohn’s Disease Drug Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Crohn’s Disease Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Crohn’s Disease Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Crohn’s Disease Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Crohn’s Disease Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Crohn’s Disease Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Crohn’s Disease Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

1 Market Overview: 1.1 Product Definition; 1.2 Crohn’s Disease Drug Market by Type; 1.2.1 Global Crohn’s Disease Drug Market Size by Type, 2020 VS 2024 VS 2031; 1.2.2 Aminosalicylates (5-ASA); 1.2.3 Antibiotics; 1.2.4 Immunomodulators; 1.2.5 Corticosteroids; 1.3 Crohn’s Disease Drug Market by Application; 1.3.1 Global Crohn’s Disease Drug Market Size by Application, 2020 VS 2024 VS 2031; 1.3.2 Pediatric Crohn'S Disease; 1.3.3 Maintaining Remission (Prevention Of Flare-Ups); 1.3.4 Achieving Remission (The Absence Of Symptoms); 1.4 Assumptions and Limitations; 1.5 Study Goals and Objectives
2 Crohn’s Disease Drug Market Dynamics: 2.1 Crohn’s Disease Drug Industry Trends; 2.2 Crohn’s Disease Drug Industry Drivers; 2.3 Crohn’s Disease Drug Industry Opportunities and Challenges; 2.4 Crohn’s Disease Drug Industry Restraints
3 Global Market Growth Prospects: 3.1 Global Crohn’s Disease Drug Revenue Estimates and Forecasts (2020-2031); 3.2 Global Crohn’s Disease Drug Revenue by Region; 3.2.1 Global Crohn’s Disease Drug Revenue by Region: 2020 VS 2024 VS 2031; 3.2.2 Global Crohn’s Disease Drug Revenue by Region (2020-2025); 3.2.3 Global Crohn’s Disease Drug Revenue by Region (2026-2031); 3.2.4 Global Crohn’s Disease Drug Revenue Market Share by Region (2020-2031); 3.3 Global Crohn’s Disease Drug Sales Estimates and Forecasts 2020-2031; 3.4 Global Crohn’s Disease Drug Sales by Region; 3.4.1 Global Crohn’s Disease Drug Sales by Region: 2020 VS 2024 VS 2031; 3.4.2 Global Crohn’s Disease Drug Sales by Region (2020-2025); 3.4.3 Global Crohn’s Disease Drug Sales by Region (2026-2031); 3.4.4 Global Crohn’s Disease Drug Sales Market Share by Region (2020-2031); 3.5 US & Canada & Mexico; 3.6 Europe; 3.7 China; 3.8 Asia (Excluding China); 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers: 4.1 Global Crohn’s Disease Drug Revenue by Manufacturers; 4.1.1 Global Crohn’s Disease Drug Revenue by Manufacturers (2020-2025); 4.1.2 Global Crohn’s Disease Drug Revenue Market Share by Manufacturers (2020-2025); 4.1.3 Global Crohn’s Disease Drug Manufacturers Revenue Share Top 10 and Top 5 in 2024; 4.2 Global Crohn’s Disease Drug Sales by Manufacturers; 4.2.1 Global Crohn’s Disease Drug Sales by Manufacturers (2020-2025); 4.2.2 Global Crohn’s Disease Drug Sales Market Share by Manufacturers (2020-2025); 4.2.3 Global Crohn’s Disease Drug Manufacturers Sales Share Top 10 and Top 5 in 2024; 4.3 Global Crohn’s Disease Drug Sales Price by Manufacturers (2020-2025); 4.4 Global Crohn’s Disease Drug Key Manufacturers Ranking, 2023 VS 2024 VS 2025; 4.5 Global Crohn’s Disease Drug Key Manufacturers Manufacturing Sites & Headquarters; 4.6 Global Crohn’s Disease Drug Manufacturers, Product Type & Application; 4.7 Global Crohn’s Disease Drug Manufacturers' Establishment Date; 4.8 Market Competitive Analysis; 4.8.1 Global Crohn’s Disease Drug Market CR5 and HHI; 4.8.2 2024 Crohn’s Disease Drug Tier 1, Tier 2, and Tier 3
5 Crohn’s Disease Drug Market by Type: 5.1 Global Crohn’s Disease Drug Revenue by Type; 5.1.1 Global Crohn’s Disease Drug Revenue by Type (2020 VS 2024 VS 2031); 5.1.2 Global Crohn’s Disease Drug Revenue by Type (2020-2031) & (US$ Million); 5.1.3 Global Crohn’s Disease Drug Revenue Market Share by Type (2020-2031); 5.2 Global Crohn’s Disease Drug Sales by Type; 5.2.1 Global Crohn’s Disease Drug Sales by Type (2020 VS 2024 VS 2031); 5.2.2 Global Crohn’s Disease Drug Sales by Type (2020-2031) & (k tons); 5.2.3 Global Crohn’s Disease Drug Sales Market Share by Type (2020-2031); 5.3 Global Crohn’s Disease Drug Price by Type
6 Crohn’s Disease Drug Market by Application: 6.1 Global Crohn’s Disease Drug Revenue by Application; 6.1.1 Global Crohn’s Disease Drug Revenue by Application (2020 VS 2024 VS 2031); 6.1.2 Global Crohn’s Disease Drug Revenue by Application (2020-2031) & (US$ Million); 6.1.3 Global Crohn’s Disease Drug Revenue Market Share by Application (2020-2031); 6.2 Global Crohn’s Disease Drug Sales by Application; 6.2.1 Global Crohn’s Disease Drug Sales by Application (2020 VS 2024 VS 2031); 6.2.2 Global Crohn’s Disease Drug Sales by Application (2020-2031) & (k tons); 6.2.3 Global Crohn’s Disease Drug Sales Market Share by Application (2020-2031); 6.3 Global Crohn’s Disease Drug Price by Application
7 Company Profiles: 7.1 Janssen Biotech; 7.1.1 Janssen Biotech Comapny Information; 7.1.2 Janssen Biotech Business Overview; 7.1.3 Janssen Biotech Crohn’s Disease Drug Sales, Revenue, Price and Gross Margin (2020-2025); 7.1.4 Janssen Biotech Crohn’s Disease Drug Product Portfolio; 7.1.5 Janssen Biotech Recent Developments; 7.2 Takeda Pharmaceuticals; 7.2.1 Takeda Pharmaceuticals Comapny Information; 7.2.2 Takeda Pharmaceuticals Business Overview; 7.2.3 Takeda Pharmaceuticals Crohn’s Disease Drug Sales, Revenue, Price and Gross Margin (2020-2025); 7.2.4 Takeda Pharmaceuticals Crohn’s Disease Drug Product Portfolio; 7.2.5 Takeda Pharmaceuticals Recent Developments; 7.3 Amgen; 7.3.1 Amgen Comapny Information; 7.3.2 Amgen Business Overview; 7.3.3 Amgen Crohn’s Disease Drug Sales, Revenue, Price and Gross Margin (2020-2025); 7.3.4 Amgen Crohn’s Disease Drug Product Portfolio; 7.3.5 Amgen Recent Developments; 7.4 AbbVie; 7.4.1 AbbVie Comapny Information; 7.4.2 AbbVie Business Overview; 7.4.3 AbbVie Crohn’s Disease Drug Sales, Revenue, Price and Gross Margin (2020-2025); 7.4.4 AbbVie Crohn’s Disease Drug Product Portfolio; 7.4.5 AbbVie Recent Developments; 7.5 Tillotts Pharma; 7.5.1 Tillotts Pharma Comapny Information; 7.5.2 Tillotts Pharma Business Overview; 7.5.3 Tillotts Pharma Crohn’s Disease Drug Sales, Revenue, Price and Gross Margin (2020-2025); 7.5.4 Tillotts Pharma Crohn’s Disease Drug Product Portfolio; 7.5.5 Tillotts Pharma Recent Developments
8 North America: 8.1 North America Crohn’s Disease Drug Market Size by Type; 8.1.1 North America Crohn’s Disease Drug Revenue by Type (2020-2031); 8.1.2 North America Crohn’s Disease Drug Sales by Type (2020-2031); 8.1.3 North America Crohn’s Disease Drug Price by Type (2020-2031); 8.2 North America Crohn’s Disease Drug Market Size by Application; 8.2.1 North America Crohn’s Disease Drug Revenue by Application (2020-2031); 8.2.2 North America Crohn’s Disease Drug Sales by Application (2020-2031); 8.2.3 North America Crohn’s Disease Drug Price by Application (2020-2031); 8.3 North America Crohn’s Disease Drug Market Size by Country; 8.3.1 North America Crohn’s Disease Drug Revenue Grow Rate by Country (2020 VS 2024 VS 2031); 8.3.2 North America Crohn’s Disease Drug Sales by Country (2020 VS 2024 VS 2031); 8.3.3 North America Crohn’s Disease Drug Price by Country (2020-2031); 8.3.4 United States; 8.3.5 Canada
9 Europe: 9.1 Europe Crohn’s Disease Drug Market Size by Type; 9.1.1 Europe Crohn’s Disease Drug Revenue by Type (2020-2031); 9.1.2 Europe Crohn’s Disease Drug Sales by Type (2020-2031); 9.1.3 Europe Crohn’s Disease Drug Price by Type (2020-2031); 9.2 Europe Crohn’s Disease Drug Market Size by Application; 9.2.1 Europe Crohn’s Disease Drug Revenue by Application (2020-2031); 9.2.2 Europe Crohn’s Disease Drug Sales by Application (2020-2031); 9.2.3 Europe Crohn’s Disease Drug Price by Application (2020-2031); 9.3 Europe Crohn’s Disease Drug Market Size by Country; 9.3.1 Europe Crohn’s Disease Drug Revenue Grow Rate by Country (2020 VS 2024 VS 2031); 9.3.2 Europe Crohn’s Disease Drug Sales by Country (2020 VS 2024 VS 2031); 9.3.3 Europe Crohn’s Disease Drug Price by Country (2020-2031); 9.3.4 Germany; 9.3.5 France; 9.3.6 U.K.; 9.3.7 Italy; 9.3.8 Netherlands; 9.3.9 Nordic Countries
10 China: 10.1 China Crohn’s Disease Drug Market Size by Type; 10.1.1 China Crohn’s Disease Drug Revenue by Type (2020-2031); 10.1.2 China Crohn’s Disease Drug Sales by Type (2020-2031); 10.1.3 China Crohn’s Disease Drug Price by Type (2020-2031); 10.2 China Crohn’s Disease Drug Market Size by Application; 10.2.1 China Crohn’s Disease Drug Revenue by Application (2020-2031); 10.2.2 China Crohn’s Disease Drug Sales by Application (2020-2031); 10.2.3 China Crohn’s Disease Drug Price by Application (2020-2031)
11 Asia (Excluding China): 11.1 Asia Crohn’s Disease Drug Market Size by Type; 11.1.1 Asia Crohn’s Disease Drug Revenue by Type (2020-2031); 11.1.2 Asia Crohn’s Disease Drug Sales by Type (2020-2031); 11.1.3 Asia Crohn’s Disease Drug Price by Type (2020-2031); 11.2 Asia Crohn’s Disease Drug Market Size by Application; 11.2.1 Asia Crohn’s Disease Drug Revenue by Application (2020-2031); 11.2.2 Asia Crohn’s Disease Drug Sales by Application (2020-2031); 11.2.3 Asia Crohn’s Disease Drug Price by Application (2020-2031); 11.3 Asia Crohn’s Disease Drug Market Size by Country; 11.3.1 Asia Crohn’s Disease Drug Revenue Grow Rate by Country (2020 VS 2024 VS 2031); 11.3.2 Asia Crohn’s Disease Drug Sales by Country (2020 VS 2024 VS 2031); 11.3.3 Asia Crohn’s Disease Drug Price by Country (2020-2031); 11.3.4 Japan; 11.3.5 South Korea; 11.3.6 India; 11.3.7 Australia; 11.3.8 Taiwan; 11.3.9 Southeast Asia
12 South America, Middle East and Africa: 12.1 SAMEA Crohn’s Disease Drug Market Size by Type; 12.1.1 SAMEA Crohn’s Disease Drug Revenue by Type (2020-2031); 12.1.2 SAMEA Crohn’s Disease Drug Sales by Type (2020-2031); 12.1.3 SAMEA Crohn’s Disease Drug Price by Type (2020-2031); 12.2 SAMEA Crohn’s Disease Drug Market Size by Application; 12.2.1 SAMEA Crohn’s Disease Drug Revenue by Application (2020-2031); 12.2.2 SAMEA Crohn’s Disease Drug Sales by Application (2020-2031); 12.2.3 SAMEA Crohn’s Disease Drug Price by Application (2020-2031); 12.3 SAMEA Crohn’s Disease Drug Market Size by Country; 12.3.1 SAMEA Crohn’s Disease Drug Revenue Grow Rate by Country (2020 VS 2024 VS 2031); 12.3.2 SAMEA Crohn’s Disease Drug Sales by Country (2020 VS 2024 VS 2031); 12.3.3 SAMEA Crohn’s Disease Drug Price by Country (2020-2031); 12.3.4 Brazil; 12.3.5 Argentina; 12.3.6 Chile; 12.3.7 Colombia; 12.3.8 Peru; 12.3.9 Saudi Arabia; 12.3.10 Israel; 12.3.11 UAE; 12.3.12 Turkey; 12.3.13 Iran; 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis: 13.1 Crohn’s Disease Drug Value Chain Analysis; 13.1.1 Crohn’s Disease Drug Key Raw Materials; 13.1.2 Raw Materials Key Suppliers; 13.1.3 Manufacturing Cost Structure; 13.1.4 Crohn’s Disease Drug Production Mode & Process; 13.2 Crohn’s Disease Drug Sales Channels Analysis; 13.2.1 Direct Comparison with Distribution Share; 13.2.2 Crohn’s Disease Drug Distributors; 13.2.3 Crohn’s Disease Drug Customers
14 Concluding Insights
15 Appendix: 15.1 Reasons for Doing This Study; 15.2 Research Methodology; 15.3 Research Process; 15.4 Authors List of This Report; 15.5 Data Source; 15.5.1 Secondary Sources; 15.5.2 Primary Sources; 15.6 Disclaimer

Pricing

Currency Rates

Single User Email from Publisher $4,950
Multi User License Fulfilled by Publisher $7,425
Global Site License Email from Publisher $9,900

How Do Licenses Work?

Request A Sample

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now